BMJ OPEN DIABETES RESEARCH & CARE

BMJ OPEN DIABETES RESEARCH & CARE Journal

publication venue for

Racial differences in measures of glycemia in the Vitamin D and Type 2 Diabetes (D2d) Study: a secondary analysis of a randomized trial. 12. 2024
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline. 10. 2022
Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE. 9. 2021
High-dose insulin infusion in patients with COVID-19 2021
Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial. 9. 2021

Electronic International Standard Serial Number (EISSN)

2052-4897

journal abbreviation

BMJ OPEN DIAB RES CA